文献
J-GLOBAL ID:201902278704000803
整理番号:19A2899148
一般化重症筋無力症の日本人患者におけるエクリズマブの長期有効性と安全性:Regainオープンラベル延長研究のサブグループ分析【JST・京大機械翻訳】
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
著者 (11件):
Murai Hiroyuki
(Department of Neurology, International University of Health and Welfare, Tokyo, Japan)
,
Uzawa Akiyuki
(Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan)
,
Suzuki Yasushi
(Department of Neurology, National Hospital Organization Sendai Medical Center, Sendai, Japan)
,
Imai Tomihiro
(Department of Neurology, Sapporo Medical University Hospital, Sapporo, Japan)
,
Shiraishi Hirokazu
(Department of Neurology, Nagasaki University Hospital, Nagasaki, Japan)
,
Suzuki Hidekazu
(Department of Neurology, Kindai University Hospital, Osaka, Japan)
,
Okumura Meinoshin
(Osaka Toneyama Medical Center, Toyonaka, Japan)
,
O’Brien Fanny
(Alexion Pharmaceuticals, Boston, MA, United States)
,
Wang Jing-Jing
(Formerly of Alexion Pharmaceuticals, Boston, MA, United States)
,
Fujita Kenji P.
(Formerly of Alexion Pharmaceuticals, Boston, MA, United States)
,
Utsugisawa Kimiaki
(Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan)
資料名:
Journal of the Neurological Sciences
(Journal of the Neurological Sciences)
巻:
407
ページ:
Null
発行年:
2019年
JST資料番号:
A1131A
ISSN:
0022-510X
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)